NR4A3 and breast cancer: The result shows that the mRNA and protein expression of NR4A3 were increased when BC cells were treated with miR-665 inhibitor, whereas they were decreased when these BC cells were transfected again with siRNAs against NR4A3 (Fig. 6b).